These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 11281563

  • 1. Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes.
    Sarobe P, Huarte E, Lasarte JJ, López-Díaz de Cerio A, García N, Borrás-Cuesta F, Prieto J.
    J Hepatol; 2001 Feb; 34(2):321-9. PubMed ID: 11281563
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Functionally distinct helper T-cell epitopes of HCV and their role in modulation of NS3-specific, CD8+/tetramer positive CTL.
    Zhu F, Eckels DD.
    Hum Immunol; 2002 Sep; 63(9):710-8. PubMed ID: 12175725
    [Abstract] [Full Text] [Related]

  • 4. Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules.
    Battegay M, Fikes J, Di Bisceglie AM, Wentworth PA, Sette A, Celis E, Ching WM, Grakoui A, Rice CM, Kurokohchi K.
    J Virol; 1995 Apr; 69(4):2462-70. PubMed ID: 7884894
    [Abstract] [Full Text] [Related]

  • 5. Cytotoxic T lymphocyte response to hepatitis C virus-derived peptides containing the HLA A2.1 binding motif.
    Cerny A, McHutchison JG, Pasquinelli C, Brown ME, Brothers MA, Grabscheid B, Fowler P, Houghton M, Chisari FV.
    J Clin Invest; 1995 Feb; 95(2):521-30. PubMed ID: 7860734
    [Abstract] [Full Text] [Related]

  • 6. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
    J Immunol; 1995 Mar 15; 154(6):2733-42. PubMed ID: 7533182
    [Abstract] [Full Text] [Related]

  • 7. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
    Chang KM, Gruener NH, Southwood S, Sidney J, Pape GR, Chisari FV, Sette A.
    J Immunol; 1999 Jan 15; 162(2):1156-64. PubMed ID: 9916747
    [Abstract] [Full Text] [Related]

  • 8. New epitope peptides derived from hepatitis C virus (HCV) 2a which have the capacity to induce cytotoxic T lymphocytes in HLA-A2+ HCV-infected patients.
    Wang Y, Takao Y, Harada M, Yutani S, Ide T, Sata M, Itoh K, Yamada A.
    Microbiol Immunol; 2006 Jan 15; 50(11):857-65. PubMed ID: 17116980
    [Abstract] [Full Text] [Related]

  • 9. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.
    Koziel MJ, Dudley D, Afdhal N, Choo QL, Houghton M, Ralston R, Walker BD.
    J Virol; 1993 Dec 15; 67(12):7522-32. PubMed ID: 7693974
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. A novel cytotoxic T-cell epitope presented by HLA-A24 molecule in hepatitis C virus infection.
    Kurokohchi K, Arima K, Nishioka M.
    J Hepatol; 2001 Jun 15; 34(6):930-5. PubMed ID: 11451179
    [Abstract] [Full Text] [Related]

  • 12. Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region.
    Kurokohchi K, Akatsuka T, Pendleton CD, Takamizawa A, Nishioka M, Battegay M, Feinstone SM, Berzofsky JA.
    J Virol; 1996 Jan 15; 70(1):232-40. PubMed ID: 8523531
    [Abstract] [Full Text] [Related]

  • 13. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
    J Med Virol; 2004 Apr 15; 72(4):575-85. PubMed ID: 14981760
    [Abstract] [Full Text] [Related]

  • 14. Identification of A2-restricted hepatitis C virus-specific cytotoxic T lymphocyte epitopes from conserved regions of the viral genome.
    Wentworth PA, Sette A, Celis E, Sidney J, Southwood S, Crimi C, Stitely S, Keogh E, Wong NC, Livingston B, Alazard D, Vitiello A, Grey HM, Chisari FV, Chesnut RW, Fikes J.
    Int Immunol; 1996 May 15; 8(5):651-9. PubMed ID: 8671652
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of interferon-alpha therapy on epitope-specific cytotoxic T lymphocyte responses in hepatitis C virus-infected individuals.
    Vertuani S, Bazzaro M, Gualandi G, Micheletti F, Marastoni M, Fortini C, Canella A, Marino M, Tomatis R, Traniello S, Gavioli R.
    Eur J Immunol; 2002 Jan 15; 32(1):144-54. PubMed ID: 11754355
    [Abstract] [Full Text] [Related]

  • 20. Induction of cytotoxic T lymphocytes with peptides in vitro: identification of candidate T-cell epitopes in hepatitis B virus X antigen.
    Chung MK, Yoon H, Min SS, Lee HG, Kim YJ, Lee TG, Lim JS, Kim CM, Park SN.
    J Immunother; 1999 Jul 15; 22(4):279-87. PubMed ID: 10404429
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.